| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.11B | 24.95B | 22.00B | 20.39B | 18.04B | 22.17B |
| Gross Profit | 7.12B | 6.96B | 5.76B | 4.66B | 4.26B | 8.54B |
| EBITDA | 5.65B | 5.52B | 4.26B | 6.93B | 2.49B | 3.71B |
| Net Income | 2.86B | 2.91B | 1.96B | 3.97B | 828.07M | 2.01B |
Balance Sheet | ||||||
| Total Assets | 94.77B | 91.10B | 85.75B | 83.56B | 96.28B | 76.37B |
| Cash, Cash Equivalents and Short-Term Investments | 3.31B | 4.06B | 2.84B | 4.54B | 1.78B | 1.27B |
| Total Debt | 796.16M | 405.20M | 806.00M | 1.21B | 2.01B | 2.02B |
| Total Liabilities | 24.40B | 23.15B | 21.95B | 21.49B | 26.59B | 20.32B |
| Stockholders Equity | 70.37B | 67.95B | 63.81B | 62.06B | 69.69B | 56.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.95B | 842.78M | 3.74B | 662.41M | -2.43B |
| Operating Cash Flow | 0.00 | 3.94B | 2.76B | 5.34B | 2.38B | 3.57B |
| Investing Cash Flow | 0.00 | -2.07B | -1.84B | -1.56B | -1.76B | -5.83B |
| Financing Cash Flow | 0.00 | -653.71M | -2.61B | -1.02B | -108.53M | 1.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥230.66B | 12.07 | 13.33% | 3.47% | 4.21% | 23.86% | |
75 Outperform | ¥33.06B | 13.48 | ― | 1.23% | 6.74% | 29.20% | |
72 Outperform | ¥73.51B | 13.94 | ― | 1.55% | 5.78% | 14.23% | |
69 Neutral | ¥62.25B | 17.12 | ― | 4.63% | 7.74% | 0.96% | |
66 Neutral | ¥37.87B | 14.70 | ― | 0.84% | 15.03% | -26.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ¥63.95B | 31.49 | ― | 1.14% | 8.17% | 10.65% |